Brixton Leadership

Founded in 2019, we are a team with the rare combination of entrepreneurialism, focus and deep scientific rigor. We keep our sights on the serious goal of eradicating pain, but enjoy levity on the way.

Brixton logo

Founding Team

R. Rox Anderson
R. Rox
Anderson, MD
Professor
Massachusetts General Hospital / Harvard Medical School
Sameer Sabir
Sameer
Sabir
Chief Executive Officer
Brixton Biosciences
Lilit Garibyan
Lilit
Garibyan, MD
Associate Professor
Massachusetts General Hospital / Harvard Medical School

Team

Charles Sidoti
Charles
Sidoti
Chief Technology Officer
Michael Fishman
Michael
Fishman, MD
Chief Medical Officer
David Curd
David
Curd
VP Clinical Development
Joanna Xylass
Joanna
Xylas, PhD
VP Medical Affairs
Olivier Kagan
Olivier
Kagan
VP Quality Assurance & Regulatory Affairs
Tom Merrill
Tom
Merrill, PhD
VP of Research
Aaron McPherson
Aaron
McPherson
Director Product Development
Zeinab Kheireddine
Zeinab
Kheireddine
Associate Director of Clinical Development
Anida Sahinovic
Anida
Sahinovic
Associate to the CEO
Danielle Brucato
Danielle
Brucato
Senior R&D Engineer
Natalie Scanlon
Natalie
Scanlon
R&D Engineer

Scientific Advisory Board

James P. Rathmell
James P.
Rathmell, MD
Chair, Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women's Hospital
Ayesha Abdeen
Ayesha
Abdeen, MD
Chief, Division of Hip and Knee Replacement at Boston Medical Center
Anis Dizdarevic
Anis
Dizdarevic, MD
Director of Anesthesia Services and Associate Professor at NewYork-Presbyterian / Columbia University Irving Medical Center

Board of Directors

Robert Forrester
Robert
Forrester
Founder and Director at IDRx
Reggie Groves
Reggie
Groves
Former VP and General Manager AF Solutions, Cardiac Rhythm and Heart Failure (CRHF) at Medtronic, Inc.
Ted Henderson
Ted
Henderson
President and CEO of
Schooner Capital
Bill McCullen
Bill
McCullen
Chief Investment Officer
at Launch Capital
Sameer
Sabir
Chief Executive Officer
at Brixton Biosciences